-
Is two months follow-up enough to identify serious vaccine side-effects?
30 November, 2020
The FDA requires that vaccine manufacturers not apply for an Emergency Use Authorisation (EUA) until at least half of the vaccine recipients in the Phase 3 trial have had at least two-months follow up...COVID-19
-
Study findings of REACT programme
United Kingdom // 30 November, 2020
Findings of a major programme of home testing for COVID-19 to track the progress of the infection across England...COVID-19
-
Sputnik V vaccine uses a different viral vector for each dose
30 November, 2020
The first dose uses adenovirus Ad26 and the second dose uses adenovirus Ad5COVID-19
-
Baby born with COVID-19 antibodies
Singapore // 29 November, 2020
A baby born to a woman infected with COVID-19 during her pregnancy has tested positive for COVID-19 antibodies....COVID-19
-
COVID-19 in minks in Poland
Poland // 28 November, 2020
First COVID-19 cases in minks...COVID-19
-
Cases rise nearly 30 percent among children
United States // 28 November, 2020
More than 144,000 children....COVID-19
-
Sputnik V vaccine is 91.4% effective according to interim data
Russia // 27 November, 2020
Russia has released interim research data from Phase 3 trials on...COVID-19
-
Sputnik V vaccine to begin production in Korea this year
South Korea // 27 November, 2020
Production will commence in December...COVID-19
-
Sinopharm applies for regulatory approval to launch vaccine
China // 27 November, 2020
Pharmaceutical company files for regulatory approval to launch...COVID-19
-
Brazil’s Sao Paulo State to receive first doses of China's Sinovac COVID-19 vaccine
Brazil // 27 November, 2020
Media reports that Sao Paulo State will begin importing 46 million doses...COVID-19
-
India may not need Pfizer vaccine
India // 27 November, 2020
Media reports Indian Health Minister as saying “India may not need Pfizer COVID-19 vaccine.”COVID-19
-
Chinese President Xi Jinping proposes global QR code system for travel
27 November, 2020
Media reports that the Chinese President has proposed using a global...COVID-19
-
Some signs AstraZeneca vaccine durability could be a year
26 November, 2020
More time is required to confirm durability of vaccine...COVID-19
-
Hint that AstraZeneca/Oxford vaccine may reduce viral transmission
26 November, 2020
Vaccination may lead to reduction in transmission...COVID-19
-
AstraZeneca to discuss with US FDA changing vaccine trial design
26 November, 2020
Media reports that AstraZeneca will start discussion...COVID-19
-
Why is the half dose then full dose Oxford vaccine regimen more efficacious?
26 November, 2020
Professor surprised by Oxford vaccine result...COVID-19
-
COVID-19 antibody prevalence studies in the United States
United States // 26 November, 2020
Seroprevalence studies have found that most people in the US do not have antibodies...COVID-19
-
COVID-19 antibodies decline within months after symptom onset: Study
26 November, 2020
COVID-19 antibodies decline around three months after peak infection...COVID-19
-
Triple Drug Therapy Shows Early Promise
United States // 25 November, 2020
Early treatment reduced hospitalisation and mortality…COVID-19
-
Study shows no evidence that SARS-CoV-2 mutations have increased transmissibility
25 November, 2020
Mutations appear to be induced by the human immune system and not signs of adaptations...COVID-19